Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Presstek is a technology company specializing in digital offset printing and direct imaging (DI) solutions, with a historical footprint in the life sciences sector. The company's proprietary imaging technology was notably adapted for the production of high-density DNA microarrays, enabling the precise deposition of biological materials for genomic research. Currently operating as a subsidiary of Mark Andy, Presstek provides high-resolution printing systems and consumables used extensively in pharmaceutical packaging, medical labeling, and the production of clinical instructions. Its business model focuses on providing efficient, high-quality printing platforms that meet the stringent regulatory and clarity requirements of the healthcare industry. The company's legacy in precision imaging continues to influence its role as a provider of specialized technology for medical information delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Presstek.